Home > Products > CD28 & EPCAM
> Anti-CD28 x Anti-EPCAM Bispecific Antibody (IgG-IgG)
Anti-CD28 x Anti-EPCAM Bispecific Antibody (IgG-IgG) (CAT#: BSIG-059)
Anti-CD28 x Anti-EPCAM Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD28 and anti-EPCAM parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Glioblastoma multiforme (GBM); Non-small cell lung (NSCLC); Colorectal cancer (CRC); Solid tumors therapy.
There are currently no customer reviews or questions for Anti-CD28 x Anti-EPCAM Bispecific Antibody (IgG-IgG) (BSIG-059). Click the button below to contact us or submit your feedback about this product.